Perkins Capital Management Inc Exagen Inc. Transaction History

Perkins Capital Management Inc

$101 Million
Q3 2025

A detailed history of Perkins Capital Management Inc transactions in Exagen Inc. stock. As of the latest transaction made, Perkins Capital Management Inc holds 20,075 shares of XGN stock, worth $181,678. This represents 0.22% of its overall portfolio holdings.

Number of Shares

20,075

Previous 231,858 91.34%

Holding current value

$181,678

Previous $1.62 Million 86.46%

% of portfolio

0.22%

Previous 1.78%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 31, 2025	SELL	$6.78 - $10.92 $1.44 Million - $2.31 Million	-211,783 Reduced 91.34%	20,075 $219,000
Q2 2025 Aug 07, 2025	SELL	$3.93 - $7.71 $751,074 - $1.47 Million	-191,113 Reduced 45.18%	231,858 $1.62 Million
Q1 2025 May 07, 2025	SELL	$2.74 - $5.33 $2,055 - $3,997	-750 Reduced 0.18%	422,971 $1.52 Million
Q4 2024 Feb 11, 2025	SELL	$2.43 - $6.0 $85,414 - $210,900	-35,150 Reduced 7.66%	423,721 $1.74 Million
Q3 2024 Oct 31, 2024	SELL	$1.74 - $3.42 $59,943 - $117,819	-34,450 Reduced 6.98%	458,871 $1.42 Million

Q2 2024 Aug 09, 2024	SELL	$1.36 - $2.05 $340 - $512	-250 Reduced 0.05%	493,321 $897,000
Q1 2024 May 09, 2024	SELL	$1.42 - $2.3 $21,774 - $35,268	-15,334 Reduced 3.01%	493,571 $784,000
Q4 2023 Jan 22, 2024	BUY	$1.45 - $2.39 $355,250 - $585,550	245,000 Added 92.84%	508,905 $1.01 Million
Q2 2023 Jul 21, 2023	BUY	$2.36 - $3.48 $9,440 - $13,920	4,000 Added 1.54%	263,905 $765,000
Q1 2023 May 09, 2023	BUY	$2.23 - $2.9 $16,725 - $21,750	7,500 Added 2.97%	259,905 $632,000
Q4 2022 Jan 26, 2023	SELL	$2.1 - $3.4 $10,605 - $17,170	-5,050 Reduced 1.96%	252,405 $606,000
Q3 2022 Oct 24, 2022	BUY	$2.69 - $8.68 $55,091 - $177,766	20,480 Added 8.64%	257,455 $698,000
Q2 2022 Jul 29, 2022	BUY	$4.18 - $7.74 $150,480 - $278,640	36,000 Added 17.91%	236,975 $1.36 Million
Q1 2022 Apr 20, 2022	BUY	$7.12 - $11.06 $10,680 - $16,590	1,500 Added 0.75%	200,975 $1.61 Million
Q4 2021 Feb 10, 2022	SELL	$8.97 - $14.08 $60,592 - $95,110	-6,755 Reduced 3.28%	199,475 $2.32 Million
Q3 2021 Oct 25, 2021	BUY	$10.25 - $15.21 $58,937 - $87,457	5,750 Added 2.87%	206,230 $2.81 Million
Q2 2021 Jul 28, 2021	SELL	$12.4 - $17.92 $37,820 - $54,656	-3,050 Reduced 1.5%	200,480 $3.01 Million
Q1 2021 Apr 28, 2021	BUY	$13.9 - $22.0 $989,332 - $1.57 Million	71,175 Added 53.78%	203,530 $3.56 Million
Q4 2020 Feb 09, 2021	BUY	$11.19 - $16.05 $134,280 - $192,600	12,000 Added 9.97%	132,355 $1.75 Million
Q3 2020 Oct 28, 2020	BUY	$10.56 - $16.69 $387,604 - $612,606	36,705 Added 43.88%	120,355 $1.31 Million
Q1 2020 Apr 29, 2020	SELL	$12.7 - $25.95 $27,940 - $57,090	-2,200 Reduced 2.56%	83,650 $1.33 Million
Q4 2019 Feb 03, 2020	SELL	$12.61 - $28.48 $20,176 - $45,568	-1,600 Reduced 1.83%	85,850 $2.18 Million
Q3 2019 Oct 23, 2019	BUY	$14.5 - $17.5 $1.27 Million - $1.53 Million	87,450 New	87,450 $1.36 Million

Others Institutions Holding XGN

# of Institutions

Shares Held

8.96M

Call Options Held

25.7K

Put Options Held

View Full List

About EXAGEN INC.

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $147M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

More about XGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.

Account

Perkins Capital Management Inc Exagen Inc. Transaction History